Unc Lineberger Comprehensive Cancer Center
Clinical trials sponsored by Unc Lineberger Comprehensive Cancer Center, explained in plain language.
-
Promising lymphoma combo trial halted early
Disease control TerminatedThis study tested a new combination of drugs (polatuzumab vedotin plus standard chemotherapy) for people with diffuse large B-cell lymphoma that returned or didn't improve after initial treatment. The goal was to see if the new combo could shrink tumors better than standard thera…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New ultrasound technique aims to sharpen cancer detection, but study stalls
Diagnosis TerminatedThis study tested a new, high-speed 3D ultrasound method called acoustic angiography to improve imaging of breast and thyroid cancers. It planned to enroll 45 people, including healthy volunteers and patients scheduled for biopsies. The goal was to see if this technique could bet…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated May 11, 2026 20:38 UTC
-
New scan technique for prostate cancer radiation shows promise
Knowledge-focused TerminatedThis study tested whether combining two advanced imaging techniques (PSMA-PET and MRI) can help doctors better target radiation for men with unfavorable-risk prostate cancer. The goal was to see if this approach is safe and feasible. Only 8 participants were enrolled before the s…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC